These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26379829)

  • 1. Transarterial chemoembolization (TACE) plus percutaneous ethanol injection (PEI) for the treatment of unresectable hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
    Fu Y; Zhao X; Yun Q; Zhu X; Zhu Y; Li Q; Hu K; Wang J; Qiao Z
    Int J Clin Exp Med; 2015; 8(7):10388-400. PubMed ID: 26379829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Li L; Tian J; Liu P; Wang X; Zhu Z
    Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Wang W; Shi J; Xie WF
    Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis on radiofrequency ablation in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Cao JH; Zhou J; Zhang XL; Ding X; Long QY
    J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):692-700. PubMed ID: 25318879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial chemoembolization in combination with local therapies for hepatocellular carcinoma: a meta-analysis.
    Liao M; Huang J; Zhang T; Wu H
    PLoS One; 2013; 8(7):e68453. PubMed ID: 23844203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Therapeutic Efficacy and Safety of Compound Kushen Injection Combined with Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma: An Update Systematic Review and Meta-Analysis.
    Ma X; Li RS; Wang J; Huang YQ; Li PY; Wang J; Su HB; Wang RL; Zhang YM; Liu HH; Zhang CE; Ma ZJ; Wang JB; Zhao YL; Xiao XH
    Front Pharmacol; 2016; 7():70. PubMed ID: 27065861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of transcatheter arterial chemoembolization used with and without apatinib for intermediate- to advanced-stage hepatocellular carcinoma: a systematic review and meta-analysis.
    Zhao S; Zhang T; Dou W; Wang E; Wang M; Wang C; Du X; Liu L
    Ann Transl Med; 2020 Apr; 8(8):542. PubMed ID: 32411765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TACE combined with PEI versus TACE alone in the treatment of HCC: a meta-analysis.
    Wang N; Guan Q; Wang K; Zhu B; Yuan W; Zhao P; Wang X; Zhao Y
    Med Oncol; 2011 Dec; 28(4):1038-43. PubMed ID: 20632218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
    Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
    Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study.
    Koda M; Murawaki Y; Mitsuda A; Oyama K; Okamoto K; Idobe Y; Suou T; Kawasaki H
    Cancer; 2001 Sep; 92(6):1516-24. PubMed ID: 11745230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Huo YR; Eslick GD
    JAMA Oncol; 2015 Sep; 1(6):756-65. PubMed ID: 26182200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular Carcinoma More Than 3 cm in Diameter: A Systematic Review of Transcatheter Arterial Chemoembolization Plus Percutaneous Ethanol Injection versus Transcatheter Arterial Chemoembolization Alone.
    Wang S; Zhuang L; Meng Z
    ISRN Gastroenterol; 2013; 2013():526024. PubMed ID: 23936659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and Safety of Combination Therapy of Transarterial Chemoembolization and Apatinib for Unresectable Hepatocellular Carcinoma in the Chinese Population: A Meta-Analysis.
    Wei Y; Liu J; Yan M; Zhao S; Long Y; Zhang W
    Chemotherapy; 2019; 64(2):94-104. PubMed ID: 31569090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.
    Dettmer A; Kirchhoff TD; Gebel M; Zender L; Malek NP; Panning B; Chavan A; Rosenthal H; Kubicka S; Krusche S; Merkesdal S; Galanski M; Manns MP; Bleck JS
    World J Gastroenterol; 2006 Jun; 12(23):3707-15. PubMed ID: 16773687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial Chemoembolization Monotherapy in Combination with Radiofrequency Ablation or Percutaneous Ethanol Injection for Hepatocellular Carcinoma.
    Xu C; Lv PH; Huang XE; Wang SX; Sun L; Wang FA
    Asian Pac J Cancer Prev; 2016; 17(9):4349-4352. PubMed ID: 27797242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of transarterial chemoembolization monotherapy, and in combination with percutaneous ethanol injection, or radiofrequency ablation therapy for hepatocellular carcinoma.
    Kirikoshi H; Saito S; Yoneda M; Fujita K; Mawatari H; Uchiyama T; Higurashi T; Goto A; Takahashi H; Abe Y; Inamori M; Kobayashi N; Kubota K; Sakaguchi T; Ueno N; Nakajima A
    Hepatol Res; 2009 Jun; 39(6):553-62. PubMed ID: 19527484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients.
    Allgaier HP; Deibert P; Olschewski M; Spamer C; Blum U; Gerok W; Blum HE
    Int J Cancer; 1998 Dec; 79(6):601-5. PubMed ID: 9842968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide combined with transarterial chemoembolization for unresectable primary hepatic carcinoma: A systematic review and meta-analysis.
    Song P; Hai Y; Ma W; Zhao L; Wang X; Xie Q; Li Y; Wu Z; Li Y; Li H
    Medicine (Baltimore); 2018 May; 97(18):e0613. PubMed ID: 29718867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of transarterial chemoembolization plus sorafenib for early or intermediate stage hepatocellular carcinoma: A systematic review and meta-analysis of randomized controlled trials.
    Zeng J; Lv L; Mei ZC
    Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):688-697. PubMed ID: 27339594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma.
    Becker G; Soezgen T; Olschewski M; Laubenberger J; Blum HE; Allgaier HP
    World J Gastroenterol; 2005 Oct; 11(39):6104-9. PubMed ID: 16273634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.